SEC Tracker
Get the app

Biovie BIVI

Biovie reduces stock offering to $1.2M

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Amendment reduces offering to $1,225,000
  2. Common stock listed on Nasdaq with symbol BIVI
  3. Public float as of Nov 4, 2026: $17,905,158.45

Written from the 424B5 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Biovie files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. Talphera TLPH public float $8M, Jun 30, 2025
  3. Processa Pharmaceuticals PCSA public float $8M, Jun 30, 2025
  4. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  5. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025